Fendly BM - Search Results

1

Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

Sliwkowski MX, Lofgren JA, Lewis GD, Hotaling TE, Fendly BM, Fox JA. Sliwkowski MX, et al. Among authors: fendly bm. Semin Oncol. 1999 Aug;26(4 Suppl 12):60-70. Semin Oncol. 1999. PMID: 10482195 Review.

2

Monoclonal antibody based ELISAs for measurement of activins in biological fluids.

Wong WL, Garg SJ, Woodruff T, Bald L, Fendly B, Lofgren JA. Wong WL, et al. J Immunol Methods. 1993 Sep 27;165(1):1-10. doi: 10.1016/0022-1759(93)90100-l. J Immunol Methods. 1993. PMID: 8409460

3

Inhibition of allergic reactions with antibodies to IgE.

Shields RL, Whether WR, Zioncheck K, O'Connell L, Fendly B, Presta LG, Thomas D, Saban R, Jardieu P. Shields RL, et al. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):308-12. doi: 10.1159/000237010. Int Arch Allergy Immunol. 1995. PMID: 7613156 Clinical Trial.

4

Anti-IgE monoclonal antibodies that inhibit allergen-specific histamine release.

Shields RL, Werther WR, Zioncheck K, O'Connell L, Klassen T, Fendly B, Presta LG, Jardieu PM. Shields RL, et al. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):412-3. doi: 10.1159/000237058. Int Arch Allergy Immunol. 1995. PMID: 7542094 No abstract available.

5

Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk.

Bennett BD, Zeigler FC, Gu Q, Fendly B, Goddard AD, Gillett N, Matthews W. Bennett BD, et al. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1866-70. doi: 10.1073/pnas.92.6.1866. Proc Natl Acad Sci U S A. 1995. PMID: 7534404 Free PMC article.

6

Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor.

Winkler ME, O'Connor L, Winget M, Fendly B. Winkler ME, et al. Biochemistry. 1989 Jul 25;28(15):6373-8. doi: 10.1021/bi00441a033. Biochemistry. 1989. PMID: 2790004

7

Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.

Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Palladino MA Jr, Ullrich A, et al. Shepard HM, et al. Among authors: fendly bm. J Clin Immunol. 1991 May;11(3):117-27. doi: 10.1007/BF00918679. J Clin Immunol. 1991. PMID: 1679763 Review.

8

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB, Slamon DJ. Pietras RJ, et al. Among authors: fendly bm. Oncogene. 1994 Jul;9(7):1829-38. Oncogene. 1994. PMID: 7911565

9

A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells.

Scott GK, Robles R, Park JW, Montgomery PA, Daniel J, Holmes WE, Lee J, Keller GA, Li WL, Fendly BM, et al. Scott GK, et al. Among authors: fendly bm. Mol Cell Biol. 1993 Apr;13(4):2247-57. doi: 10.1128/mcb.13.4.2247. Mol Cell Biol. 1993. PMID: 8096058 Free PMC article.

10

Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.

Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX. Lewis GD, et al. Among authors: fendly bm. Cancer Res. 1996 Mar 15;56(6):1457-65. Cancer Res. 1996. PMID: 8640840 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results